Clinical Trial Update: Mirikizumab Real World Protocol

View source ↗

Summary

A real-world protocol study evaluating mirikizumab for ulcerative colitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Mirikizumab (mirikizumab)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Ulcerative Colitis | Status: RECRUITING